Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
National-scale initiative will profile ~21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias (ADRD) participants using Alamar Biosciences’ NULISAseq™ Neuro 220 panel.
Read the full articleYou might also wanna read
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Conditions : Alzheimer Blood Biomarkers; Alzheimer's Disease (AD) Interventions : Diagnostic Test: Plasma p-tau217 and neurofilament light c
Experimental blood test detects multiple dementia types with 92% accuracy
AI helped researchers develop an experimental blood test that might let doctors diagnose overlapping dementias.
Experimental blood test detects multiple dementia types with 92% accuracy
AI helped researchers develop an experimental blood test that might let doctors diagnose overlapping dementias.
Experimental blood test detects multiple dementia types with 92% accuracy
AI helped researchers develop an experimental blood test that might let doctors diagnose overlapping dementias.
Blood Biomarkers to Detect Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the di
Blood Biomarkers to Detect Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the di
Blood Biomarkers to Detect Alzheimer Disease - Part 2
In part two of this series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss how this new blood test can enhance the accuracy of diagnosing
ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial Readiness
Conditions : Alzheimer Sponsors : Firalis SA; CHU de Reims; University Hospital, Marseille; Centre Hospitalier Universitaire de Nice; Univer

Comments
Sign in to join the conversation.
No comments yet. Be the first.